Introduction: Obstructive sleep apnoea (OSA) is a serious but underdiagnosed condition. Demand for the gold standard diagnostic polysomnogram (PSG) far exceeds its availability. More efficient diagnostic methods are needed, even in tertiary settings. Machine learning (ML) models have strengths in disease prediction and early diagnosis. We explored the use of ML with oximetry, demographic and anthropometric data to diagnose OSA. Methods: A total of 2,996 patients were included for modelling and divided into test and training sets. Seven commonly used supervised learning algorithms were trained with the data. Sensitivity (recall), specificity, positive predictive value (PPV) (precision), negative predictive value, area under the receiver operating characteristic curve (AUC) and F1 measure were reported for each model. Results: In the best performing four-class model (neural network model predicting no, mild, moderate or severe OSA), a prediction of moderate and/or severe disease had a combined PPV of 94%; one out of 335 patients had no OSA and 19 had mild OSA. In the best performing two-class model (logistic regression model predicting no–mild vs. moderate–severe OSA), the PPV for moderate–severe OSA was 92%; two out of 350 patients had no OSA and 26 had mild OSA. Conclusion: Our study showed that the prediction of moderate–severe OSA in a tertiary setting with an ML approach is a viable option to facilitate early identification of OSA. Prospective studies with home-based oximeters and analysis of other oximetry variables are the next steps towards formal implementation.
Study objectives Obstructive sleep apnea (OSA) is a prevalent but underdiagnosed condition linked to serious health risks. Due to the limited accessibility of polysomnography (PSG), AI (Artificial Intelligence)-based speech analysis has gained attention as a non-invasive screening tool. This Bayesian meta-analysis evaluates the diagnostic accuracy of AI models trained on awake speech and examines factors affecting performance. Methods We systematically searched Medline/PubMed, Embase, Scopus, Web of Science, and IEEE Xplore databases. Eligible studies included adults with OSA diagnosis via in-lab polysomnography or home sleep apnea tests and evaluated AI models using speech recordings. Models evaluated using random-split test sets or k-fold cross-validation were included in a Bayesian bivariate meta-analysis and meta-regression. Publication bias was examined using a selection model approach, while risk of bias and evidence quality were assessed with QUADAS-2 and GRADE. Results From 6,254 screened articles, 8 studies comprising 24 AI models, trained and tested on 1,060 and 825 participants were included. All studies used professional microphone recordings in the controlled hospital settings. AI models analysing awake speech recordings demonstrated pooled sensitivity and specificity of 82.9% (95% CrI: 80.0–86.4%) and 83.3% (95% CrI: 80.7–86.1%), respectively. The diagnostic odds ratio was 24.3 (95% CrI: 18.2–35.0). Higher mean age improved sensitivity. No significant effects were seen for OSA severity, model type, OSA prevalence, or male percentage. Publication bias was not evident. Conclusion AI models trained on awake speech recordings demonstrate good diagnostic accuracy for OSA and hold potential as a practical, scalable screening tool in both clinical and community-based settings.
16 November 2025 in European Archives of Oto-Rhino-Laryngology
Objective: Retrograde cricopharyngeal dysfunction (RCPD) is characterised by an inability to burp. Typical first‐line management involves injection of Botulinum A toxin (BonT‐A) into the cricopharyngeus. We present our series of 109 RCPD patients. Methods: A retrospective chart review was conducted between January 2018 and November 2024. Demographics and clinical data were extracted. From late 2021 onwards, we also started collecting scores from a 7‐point Likert questionnaire based on the six cardinal symptoms of RCPD (RCPD‐Q in short). Results: A109 patients were identified. Sixty‐two (56.9%) were female. Mean age was 30.0 (range: 14–72). The majority (91.7%) were of Caucasian ethnicity. Eighty patients completed the RCPD‐Q at their initial consultation, with a mean score of 27.6/36 (range: 13–36). Seventy‐four patients underwent initial treatment. At first follow‐up within 4 weeks, 53 patients (71.6%) had complete resolution, 11 (14.9%) had partial resolution and seven (9.5%) had no change in symptoms. In the 30 patients who completed follow‐up at > 3 months after treatment, 17 patients (56.7%) reported complete resolution, three patients (10%) reported partial resolution and 10 patients (33.3%) reported no resolution or reversion to baseline symptoms. Conclusion: Younger age, treatment under general anaesthesia, and higher doses of BonT‐A were associated with higher rates of success. Level of Evidence: Level 3.